First-in-class diabetes drug launches in UK

A novel class of blood glucose-lowering treatment for type 2 diabetes has launched in the UK after gaining European approval, offering GPs new treatment options.

Finger prick: new class of diabetes drugs approved
Finger prick: new class of diabetes drugs approved

Dapagliflozin (Forxiga) belongs to a new drug class called sodium-glucose cotransporter 2 (SGLT2) inhibitors, which work by reducing the amount of glucose reabsorbed by the kidney.

This means it can be prescribed alongside other glucose-lowering drugs, including insulin, when these treatments along with changes in diet and exercise do not provide sufficient blood glucose control. It can also be used as monotherapy when metformin is not tolerated.

A study found reductions in blood glucose with dapagliflozin were similar to those in patients treated with a sulphonylurea plus metformin.

Research has also suggested dapagliflozin plus metformin can also encourage weight loss averaging 3.7kg over two years, compared with weight gain of 1.36kg among patients on sulphonylurea plus metformin.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

MPs demand overhaul of 'entire approach to pension tax relief' ahead of budget

MPs demand overhaul of 'entire approach to pension tax relief' ahead of budget

MPs have called on chancellor Rishi Sunak to 'urgently reform the entire approach...

Government must halt 'stealth privatisation' of dozens of GP practices, warns Labour

Government must halt 'stealth privatisation' of dozens of GP practices, warns Labour

Labour has urged the government to halt the 'stealth privatisation' of dozens of...

RCGP demands independent review to check for BAME bias in CQC ratings

RCGP demands independent review to check for BAME bias in CQC ratings

CQC inspections on all practices rated 'requires improvement' or 'inadequate' in...

COVID-19 funding for general practice cannot stop in March, GPs warn chancellor

COVID-19 funding for general practice cannot stop in March, GPs warn chancellor

COVID-19 support funding for general practice must be increased and extended beyond...

Plan to freeze pensions lifetime allowance risks 'catastrophic impact' on medical workforce

Plan to freeze pensions lifetime allowance risks 'catastrophic impact' on medical workforce

The BMA has demanded urgent meetings with the Treasury and DHSC amid fears chancellor...